Literature DB >> 22222858

Hemifacial spasm: clinical characteristics of 321 Indian patients.

Amit Batla1, Chanchal Goyal, Garima Shukla, Vinay Goyal, Achal Srivastava, Madhuri Behari.   

Abstract

Hemifacial spasm (HFS) is a common neurological disorder characterized by involuntary tonic and clonic contractions of the muscles innervated by the facial nerve. We aimed to describe clinical features, common antecedents, triggers and relieving factors in patients with hemifacial spasm to study the correlation of hypertension and HFS, and to compare clinical features of primary and secondary cases of HFS. The data for the study were collected prospectively on a predesigned and pre-tested format at the first attendance in all consecutive HFS patients attending the movement disorders clinic of a tertiary teaching hospital in India. The demographic profile, HFS symptoms, antecedent illnesses and neurological examination were recorded and analyzed. Muscle power in individual muscles innervated by the facial nerve was tested carefully before botulinum toxin injection. Hemifacial spasm occurred in 7.14% (n = 582) of 8,151 cases registered at the movement disorders clinic from 1993 to 2010. Data of 321 patients were complete and were included in the study. Females constituted 49.22% (n = 158). The mean age the patients was 46.02 ± 11.82 years; ipsilateral ear clicking was observed in 22.74% cases. The most common aggravating factor was stress (44.86%), while the most common relieving factor was sleep (44.24%). Two hundred fifty-two patients (78.5%) had primary HFS. The severity of spasm correlated significantly with disease duration (p < 0.001) and weakness of facial muscles (p < 0.001). We did not observe any correlation between HFS on the left side and hypertension, as has been reported earlier. This is one of the largest studies of HFS patients and the only one that prospectively assesses patients with HFS clinically on their first visit. Interesting observations of this study are lack of female preponderance, presence of clicking in the ipsilateral ear and facial weakness even prior to botulinum toxin injection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22222858     DOI: 10.1007/s00415-011-6376-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  17 in total

1.  The other Babinski sign in hemifacial spasm.

Authors:  William Stamey; Joseph Jankovic
Journal:  Neurology       Date:  2007-07-24       Impact factor: 9.910

2.  Pathophysiology of hemifacial spasm: I. Ephaptic transmission and ectopic excitation.

Authors:  V K Nielsen
Journal:  Neurology       Date:  1984-04       Impact factor: 9.910

3.  Hemifacial spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984.

Authors:  R G Auger; J P Whisnant
Journal:  Arch Neurol       Date:  1990-11

4.  Asian over-representation among patients with hemifacial spasm compared to patients with cranial-cervical dystonia.

Authors:  Yuncheng Wu; Anthony L Davidson; Tianhong Pan; Joseph Jankovic
Journal:  J Neurol Sci       Date:  2010-11-15       Impact factor: 3.181

5.  Risk factors of Parkinson's disease in Indian patients.

Authors:  M Behari; A K Srivastava; R R Das; R M Pandey
Journal:  J Neurol Sci       Date:  2001-09-15       Impact factor: 3.181

6.  Monitoring of facial muscle motor evoked potentials during microvascular decompression for hemifacial spasm: evidence of changes in motor neuron excitability.

Authors:  Marshall F Wilkinson; Anthony M Kaufmann
Journal:  J Neurosurg       Date:  2005-07       Impact factor: 5.115

7.  Relationship between anterior inferior cerebellar artery and facial-vestibulocochlear nerve complex: an anatomical and magnetic resonance images correlation study.

Authors:  T Yurtseven; R Savaş; A Koçak; T Turhan; E O Aktaş; S Işlekel
Journal:  Minim Invasive Neurosurg       Date:  2004-10

8.  Clinical assessment of patients with primary and postparalytic hemifacial spasm: a retrospective study.

Authors:  Andre Carvalho Felicio; Clecio de Oliveira Godeiro-Junior; Vanderci Borges; Sonia Maria de Azevedo Silva; Henrique Ballalai Ferraz
Journal:  Arq Neuropsiquiatr       Date:  2007-09       Impact factor: 1.420

9.  Axonal excitability properties in hemifacial spasm.

Authors:  Arun V Krishnan; Michael Hayes; Matthew C Kiernan
Journal:  Mov Disord       Date:  2007-07-15       Impact factor: 10.338

10.  Classification of neurovascular compression in typical hemifacial spasm: three-dimensional visualization of the facial and the vestibulocochlear nerves.

Authors:  Ramin Naraghi; Levent Tanrikulu; Regina Troescher-Weber; Barbara Bischoff; Martin Hecht; Michael Buchfelder; Peter Hastreiter
Journal:  J Neurosurg       Date:  2007-12       Impact factor: 5.115

View more
  5 in total

Review 1.  Botulinum Toxin Treatment of Movement Disorders.

Authors:  Yasaman Safarpour; Bahman Jabbari
Journal:  Curr Treat Options Neurol       Date:  2018-02-24       Impact factor: 3.598

Review 2.  Hemifacial spasm and neurovascular compression.

Authors:  Alex Y Lu; Jacky T Yeung; Jason L Gerrard; Elias M Michaelides; Raymond F Sekula; Ketan R Bulsara
Journal:  ScientificWorldJournal       Date:  2014-10-28

Review 3.  History of Botulinum Toxin Treatment in Movement Disorders.

Authors:  Bahman Jabbari
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-11-28

4.  Role of neuroimaging in cases of primary and secondary hemifacial spasm.

Authors:  Prabrisha Banerjee; Md Shahid Alam; Kirthi Koka; Ruchi Pherwani; Olma Veena Noronha; Bipasha Mukherjee
Journal:  Indian J Ophthalmol       Date:  2021-02       Impact factor: 1.848

Review 5.  Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies.

Authors:  Nicola Tambasco; Marta Filidei; Pasquale Nigro; Lucilla Parnetti; Simone Simoni
Journal:  Toxins (Basel)       Date:  2021-12-09       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.